Antibiotic-lock therapy for long-term catheter-related bacteremia: A review of the current evidence

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 4, 2007, Pages 639-652

  Korbila, Ioanna P ^a,b   Bliziotis, Ioannis A ^a,c   Lawrence, Kenneth R ^d   Falagas, Matthew E ^a  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b 417 Army Share Found Hospital   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Amikacin; Catheter related bloodstream infection; Central venous catheter; Ciprofloxacin; Heparin; Totally implanted device; Tunneled; Vancomycin

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; HEPARIN; LEVOFLOXACIN; METICILLIN; METRONIDAZOLE; MEZLOCILLIN; MINOCYCLINE; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PLACEBO; POVIDONE; TAUROLIDINE; TEICOPLANIN; UNINDEXED DRUG; UROKINASE; VANCOMYCIN;

ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTEREMIA; CANCER PATIENT; CATHETER CARE; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; EVIDENCE BASED MEDICINE; HEMODIALYSIS PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTIOUS COMPLICATION; INSTRUMENT STERILIZATION; LONG TERM CARE; MONOTHERAPY; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT SELECTION; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; HUMANS;

EID: 34547889911     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.4.639     Document Type: Review

References (45)

1. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect. Control Hosp. Epidemiol. 20(3), 187-191 (1999).
2. Kellerman S, Shay DK, Howard J et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J. Pediatr. 129(5), 711-717 (1996).
3. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81(9), 1159-1171 (2006).
4. Mermel LA, Farr BM, Sherertz RJ et al; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32(9), 1249-1272 (2001).
5. Sherertz RJ, Boger MS, Collins CA, Mason L, Raad II. Comparative in vitro efficacies of various catheter lock solutions. Antimicrob. Agents Chemother. 50(5), 1865-1868 (2006).
6. Lee JY, Ko KS, Peck KR, Oh WS, Song JH. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci. J. Antimicrob. Chemother. 57(6), 1110-1115 (2006).
7. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin. Infect. Dis. 43(4), 474-484 (2006).
8. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol. Dial. Transplant. 19(5), 1237-1244 (2004).
9. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J. Antimicrob. Chemother. 55(1), 90-94 (2005).
10. Fortun J, Grill F, Martin-Davila P et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J. Antimicrob. Chemother. 58(4), 816-821 (2006).
11. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J. Parenter. Enteral. Nutr. 12(2), 185-189 (1998).
12. Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin. Nutr. 9(4), 220-225 (1990).
13. Williams N, Carlson GL, Scott NA, Irving MH. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br. J. Surg. 81(3), 392-394 (1994).
14. Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. J. Parenter. Enteral. Nutr. 26(2), 104-108 (2002).
15. Guedon C, Nouvellon M, Lalaude O, Lerebours E. Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. J. Parenter. Enteral. Nutr. 26(2), 109-113 (2002).
16. Santarpia L, Pasanisi F, Alfonsi L et al. Prevention and treatment of implanted central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin. Nutr. 21(3), 207-211 (2002).
17. Reimund JM, Arondel Y, Finck G, Zimmermann F, Duclos B, Baumann R. Catheter-related infection in patients on home parenteral nutrition: results of a prospective survey. Clin. Nutr. 21(1), 33-38 (2002).
18. Capdevila JA, Segarra A, Planes AM et al. Long-term follow-up of patients with catheter-related bacteremia treated without catheter removal. Clin. Microbiol. Infect. 4, 472-476 (1988).
19. Boorgu R, Dubrow AJ, Levin NW et al. Adjunctive antibiotic/ anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J. 46(6), 767-770 (2000).
20. Bailey E, Betty N, Cheesbrough JS. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J. Antimicrob. Chemother. 50(4), 615-617 (2002).
21. Krishnasami Z, Carlton D, Bimbo L et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 61(3), 1136-1142 (2002).
22. Vardhan A, Davies J, Daryanani I, Crowe A, McClelland P. Treatment of haemodialysis catheter-related infections. Nephrol. Dial. Transplant. 17(6), 1149-1150 (2002).
23. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J. Hosp. Infect. 22(2), 109-116 (1992).
24. Capdevila JA, Barbera J, Gavalda J et al. Diagnosis and conservative management (CM) of infection related to long term venous catheterization (CI) in AIDS patients (abstract J 55). Presented at: The 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL, USA, 4-7 October 1994.
25. Longuet P, Douard MC, Maslo C, Benoit C, Arlet G, Leport C. Limited efficacy of antibiotic lock technique in catheter related bacteremia of totally implanted ports in HIV infected and oncology patients. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. American Society for Microbiology. Washington DC, USA 257 (1995).
26. McCarthy A, Byrne M, Breathnach F, O'Meara A. "In situ" teicoplanin for central venous catheter infection. Ir. J. Med. Sci. 164(2), 125-127 (1995).
27. Piketty C, Hoi AB, Gilquin J et al. Failure of antibiotic therapy in Staphylococcus epidermidis infection of implantable venous access devices in patients with AIDS, as documented by molecular typing. Clin. Microbiol. Infect. 5(4), 190-194 (1999).
28. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin. Infect. Dis. 32(12), 1776-1783 (2001).
29. De Sio L, Jenkner A, Milano GM et al. Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients. Pediatr. Infect. Dis. J. 23(10), 963-965 (2004).
30. Bernardi M, Cavaliere M, Cesaro S. [The antibiotic-lock therapy in oncoematology pediatric unit]. Assist. Inferm. Ric. 24(3), 127-131 (2005).
31. Sanchez-Munoz A, Aguado JM, Lopez-Martin A et al. Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. Eur. J. Clin. Microbiol. Infect. Dis. 24(4), 291-293 (2005).
32. Johnson JR. Issues in the management of intravascular catheter-related infections. Clin. Infect. Dis. 33(11), 1948-1949 (2001).
33. Krzywda EA, Andris DA, Edmiston CE Jr, Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control Hosp. Epidemiol. 116(10), 596-581 (1995).
34. Viale P, Pagani L, Petrosillo N et al; Italian Hospital and HIV Infection Group. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J. Chemother. 15(2), 152-156 (2003).
35. Fernandez-Hidalgo N, Almirante B, Calleja R et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J. Antimicrob. Chemother. 57(6), 1172-1180 (2006).
36. Gilbert DN, Dworkin RJ, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. N. Engl. J. Med. 337(12), 829-838 (1997).
37. Blot SI, Depuydt P, Annemans L et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin. Infect. Dis. 41(11), 1591-1598 (2005).
38. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34(6), 730-751 (2002).
39. Fatkenheuer G, Buchheidt D, Cornely OA et al; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Central venous catheter (CVC)-related infections in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann. Hematol. 82(Suppl. 2), S149-S157 (2003).
40. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51(RR-10), 1-29 (2002).
41. Domingo P, Fontanet A, Sanchez F, Allende L, Vazquez G. Morbidity associated with long-term use of totally implantable ports in patients with AIDS. Clin. Infect. Dis. 29(2), 346-351 (1999).
42. Gaillard JL, Merlino R, Pajot N et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. J. Parenter. Enteral. Nutr. 14(6), 593-597 (1990).
43. Andris DA, Krzywda EA, Edmiston CE, Krepel CJ, Gohr CM. Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters. Nutrition 14(5), 427-432 (1998).
44. Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int. J. Antimicrob. Agents 24(5), 491-495 (2004).
45. Shah CB, Mittelman MW, Costerton JW et al. Antimicrobial activity of a novel catheter lock solution. Antimicrob. Agents Chemother. 46(6), 1674-1679 (2002).